Resistance in Vancomycin-Resistant Enterococci

William R. Miller; Barbara E. Murray; Louis B. Rice; Cesar A. Arias

doi:10.1016/j.idc.2020.08.004

Resistance in Vancomycin-Resistant Enterococci

William R. Miller, Barbara E. Murray, Louis B. Rice, Cesar A. Arias

Research output: Contribution to journal › Review article › peer-review

112 Scopus citations

Abstract

Serious infections owing to vancomycin-resistant enterococci have historically proven to be difficult clinical cases, requiring combination therapy and management of treatment-related toxicity. Despite the introduction of new antibiotics with activity against vancomycin-resistant enterococci to the therapeutic armamentarium, significant challenges remain. An understanding of the factors driving the emergence of resistance in vancomycin-resistant enterococci, the dynamics of gastrointestinal colonization and microbiota-mediated colonization resistance, and the mechanisms of resistance to the currently available therapeutics will permit clinicians to be better prepared to tackle these challenging hospital-associated pathogens.

Original language	English (US)
Pages (from-to)	751-771
Number of pages	21
Journal	Infectious Disease Clinics of North America
Volume	34
Issue number	4
DOIs	https://doi.org/10.1016/j.idc.2020.08.004
State	Published - Dec 2020

Keywords

Colonization resistance
Mechanisms of resistance
VRE
VRE colonization
Vancomycin resistant enterococcus

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Divisions

Infectious Disease

Access to Document

10.1016/j.idc.2020.08.004

Cite this

@article{38fa2c604f72467fb4c143d3aff4b8a1,

title = "Resistance in Vancomycin-Resistant Enterococci",

abstract = "Serious infections owing to vancomycin-resistant enterococci have historically proven to be difficult clinical cases, requiring combination therapy and management of treatment-related toxicity. Despite the introduction of new antibiotics with activity against vancomycin-resistant enterococci to the therapeutic armamentarium, significant challenges remain. An understanding of the factors driving the emergence of resistance in vancomycin-resistant enterococci, the dynamics of gastrointestinal colonization and microbiota-mediated colonization resistance, and the mechanisms of resistance to the currently available therapeutics will permit clinicians to be better prepared to tackle these challenging hospital-associated pathogens.",

keywords = "Colonization resistance, Mechanisms of resistance, VRE, VRE colonization, Vancomycin resistant enterococcus",

author = "Miller, \{William R.\} and Murray, \{Barbara E.\} and Rice, \{Louis B.\} and Arias, \{Cesar A.\}",

note = "Publisher Copyright: {\textcopyright} 2020 Elsevier Inc.",

year = "2020",

month = dec,

doi = "10.1016/j.idc.2020.08.004",

language = "English (US)",

volume = "34",

pages = "751--771",

journal = "Infectious Disease Clinics of North America",

issn = "0891-5520",

publisher = "W.B. Saunders",

number = "4",

}

TY - JOUR

T1 - Resistance in Vancomycin-Resistant Enterococci

AU - Miller, William R.

AU - Murray, Barbara E.

AU - Rice, Louis B.

AU - Arias, Cesar A.

PY - 2020/12

Y1 - 2020/12

N2 - Serious infections owing to vancomycin-resistant enterococci have historically proven to be difficult clinical cases, requiring combination therapy and management of treatment-related toxicity. Despite the introduction of new antibiotics with activity against vancomycin-resistant enterococci to the therapeutic armamentarium, significant challenges remain. An understanding of the factors driving the emergence of resistance in vancomycin-resistant enterococci, the dynamics of gastrointestinal colonization and microbiota-mediated colonization resistance, and the mechanisms of resistance to the currently available therapeutics will permit clinicians to be better prepared to tackle these challenging hospital-associated pathogens.

AB - Serious infections owing to vancomycin-resistant enterococci have historically proven to be difficult clinical cases, requiring combination therapy and management of treatment-related toxicity. Despite the introduction of new antibiotics with activity against vancomycin-resistant enterococci to the therapeutic armamentarium, significant challenges remain. An understanding of the factors driving the emergence of resistance in vancomycin-resistant enterococci, the dynamics of gastrointestinal colonization and microbiota-mediated colonization resistance, and the mechanisms of resistance to the currently available therapeutics will permit clinicians to be better prepared to tackle these challenging hospital-associated pathogens.

KW - Colonization resistance

KW - Mechanisms of resistance

KW - VRE

KW - VRE colonization

KW - Vancomycin resistant enterococcus

UR - https://www.scopus.com/pages/publications/85094609126

UR - https://www.scopus.com/inward/citedby.url?scp=85094609126&partnerID=8YFLogxK

U2 - 10.1016/j.idc.2020.08.004

DO - 10.1016/j.idc.2020.08.004

M3 - Review article

C2 - 33131572

AN - SCOPUS:85094609126

SN - 0891-5520

VL - 34

SP - 751

EP - 771

JO - Infectious Disease Clinics of North America

JF - Infectious Disease Clinics of North America

IS - 4

ER -

Resistance in Vancomycin-Resistant Enterococci

Abstract

Keywords

ASJC Scopus subject areas

Divisions

Access to Document

Other files and links

Fingerprint

Cite this